Related Experiment Video
Updated: Jul 5, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Moving beyond tight glucose control to safe effective glucose control
James S Krinsley1, Jean-Charles Preiser
1Division of Critical Care, Stamford Hospital, 190 West Broad Street, Stamford, CT 06902, USA.
Critical Care (London, England)
|May 23, 2008
Summary
Intensive insulin therapy for tight glucose control has shown limited success in large trials. A stepwise approach, Safe, Effective Glucose Control, targets intermediate blood glucose levels to reduce hypoglycemia and workload.
Area of Science:
- Critical care medicine
- Endocrinology
- Clinical trials
Background:
- Intensive insulin therapy aims for tight glucose control, but benefits are not consistently replicated in large trials.
- Reasons for the failure to reproduce benefits of tight glucose control remain unclear.
- Severe hyperglycemia and hypoglycemia pose significant risks in critical care settings.
Purpose of the Study:
- To propose and evaluate a stepwise approach, Safe, Effective Glucose Control (SEGC), for managing blood glucose levels.
- To compare SEGC with traditional tight glucose control in terms of efficacy and safety.
- To reduce hypoglycemia rates and clinical workload while mitigating severe hyperglycemia.
Main Methods:
- The study suggests a stepwise approach targeting intermediate blood glucose levels.
- Safe, Effective Glucose Control is already implemented in numerous intensive care units globally.
- Comparison is made against genuine tight glucose control strategies.
Main Results:
- Safe, Effective Glucose Control aims to decrease the incidence of hypoglycemia.
- This approach is designed to reduce the workload for healthcare professionals.
- The strategy also seeks to minimize adverse effects associated with severe hyperglycemia.
Conclusions:
- The Safe, Effective Glucose Control approach offers a viable alternative to tight glucose control.
- This method shows promise in balancing glycemic targets with patient safety and resource management.
- Further research may validate its widespread application in intensive care units.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...